Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Equivalency of ondansetron + dexamethasone + olanzapine vs netupitant regimen for prevention of cisplatin-induced nausea and vomiting
TCTR20190508001Phase 3Recruiting
- Sponsor
- N/A
- Start
- Apr 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ondansetron, dexamethasone, olanzapine and netupitant in chemotherapy-induced nausea and vomiting (CINV) (2 arms), sponsored by N/A. Primary endpoint: Complete response rate (no emesis and no use of rescue medication). Started Apr 2019; status: recruiting.
02
Drugs
ondansetrondexamethasoneolanzapinenetupitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on TCTR20190508001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190508001.